McIlrath & Eck’s Adient ADNT Stock Holding History

McIlrath & Eck’s Portfolio ADNT Stock Details ADNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-2	Closed	-$73	–	937
2023 Q4	$73	Buy	+2	New	+$69	﹤0.01%	912
2018 Q2	–	Sell	-66	Closed	-$4K	–	513
2018 Q1	$4K	Hold	66	–	–	﹤0.01%	363
2017 Q4	$5K	Buy	+66	New	+$5.32K	﹤0.01%	357

Other funds holding ADNT

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

McIlrath & Eck's ADNT Position: Q1 2024 in Review

McIlrath & Eck sold out of Adient (ADNT) in Q1 2024, closing a stake of 2 shares — an estimated $73 sold.

McIlrath & Eck first reported a position in ADNT in Q4 2017 and held it in 3 quarters. The position peaked at $5K in Q4 2017. 312 funds tracked by Wall St. Rank hold ADNT as of Q1 2024.

McIlrath & Eck reported no remaining Adient position as of Q1 2024 after selling out during the quarter.
McIlrath & Eck sold 2 Adient shares in Q1 2024, an estimated $73.
McIlrath & Eck first reported a position in Adient in Q4 2017 and held it in 3 quarters.
McIlrath & Eck's Adient position peaked at $5K in Q4 2017.
312 funds tracked by Wall St. Rank held Adient as of Q1 2024.

Based on McIlrath & Eck's 13F filing for Q1 2024, filed 10 May 2024.